Hao Jianqing, Wang Helin, Song Lai, Li Shuping, Che Nanying, Zhang Shucai, Zhang Hongtao, Wang Jinghui
Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing, China.
Department of Oncology, First Affiliated Hospital of Xinxiang Medical University Xinxiang, Henan, China.
Int J Clin Exp Pathol. 2020 May 1;13(5):880-888. eCollection 2020.
Studies about CD8 FOXP3 T cells as a subtype of regulatory T cells (Treg cells) in non-small cell lung cancer (NSCLC) are few. Associations among the clinicopathologic factors of NSCLC and tumor-infiltrating lymphocytes (TILs) such as CD8 FOXP3 T cells, CD8 T cells, FOXP3 T cells and tumor PD-L1 expression are unclear.
We retrospectively enrolled 192 patients who underwent resections for NSCLC. We used tissue microarrays (TMA) with multiplex immunofluorescence and immunohistochemistry staining to evaluate the expression of CD8, FOXP3, cytokeratin, DAPI and PD-L1. We then used Wilcoxon test, Kaplan-Meier method, and Cox hazard proportion model to analyze their relationships with clinicopathologic factors and prognosis.
Density of tumor CD8 FOXP3 T cells was significant by univariate analysis, and positively associated with tumor CD8 T cells and FOXP3 T cells. Density of tumor CD8 T cells was higher in lung adenocarcinoma (LUAD) than squamous cell carcinoma (LUSC), and was an independent prognostic factor for NSCLC. The density of tumor FOXP3 T cells decreased with tumor size. Tumor PD-L1 expression was higher in LUSC than LUAD. Cox hazard proportion model analysis correlated being younger than 65 years, early TNM stage, early T stage, high tumor CD8 T cell density, and adjuvant chemotherapy with longer overall survival.
Infiltration of CD8 FOXP3 T cells, CD8 T cells, and FOXP3 T cells is important in non-small cell lung cancer microenvironment, and needs to be investigated more.
关于CD8 FOXP3 T细胞作为非小细胞肺癌(NSCLC)中调节性T细胞(Treg细胞)亚型的研究较少。NSCLC的临床病理因素与肿瘤浸润淋巴细胞(TILs)如CD8 FOXP3 T细胞、CD8 T细胞、FOXP3 T细胞以及肿瘤PD-L1表达之间的关联尚不清楚。
我们回顾性纳入了192例行NSCLC切除术的患者。我们使用组织微阵列(TMA)进行多重免疫荧光和免疫组织化学染色,以评估CD8、FOXP3、细胞角蛋白、DAPI和PD-L1的表达。然后我们使用Wilcoxon检验、Kaplan-Meier方法和Cox风险比例模型来分析它们与临床病理因素及预后的关系。
单因素分析显示肿瘤CD8 FOXP3 T细胞密度具有显著性,且与肿瘤CD8 T细胞和FOXP3 T细胞呈正相关。肺腺癌(LUAD)中肿瘤CD8 T细胞密度高于肺鳞癌(LUSC),并且是NSCLC的独立预后因素。肿瘤FOXP3 T细胞密度随肿瘤大小增加而降低。LUSC中肿瘤PD-L1表达高于LUAD。Cox风险比例模型分析显示,年龄小于65岁、早期TNM分期、早期T分期、高肿瘤CD8 T细胞密度以及辅助化疗与更长的总生存期相关。
CD8 FOXP3 T细胞、CD8 T细胞和FOXP3 T细胞的浸润在非小细胞肺癌微环境中具有重要意义,需要进一步研究。